22.70 USD
↘ 8.45 (28.70%)PRE MARKET (AS OF Fri 05:29 AM EDT)
AKTS Stock Premarket
Aktis Oncology, Inc. Common stock
AKTSNASDAQ • USD
Market: CLOSED
Premarket trading runs 4:00 AM – 9:30 AM ET.
AKTS last traded at $22.70 in premarket, down $8.45 (28.70%) from its previous close of $31.15.
📅 AKTS is expected to report earnings around Sep 2, 2026 (estimated), with an estimated EPS of $-0.42. AKTS earnings details →
AKTS Premarket Chart
AKTS Premarket News
Gap Analytics — 5-year history, 5% minimum gap
No qualifying gap events found for AKTS.
Frequently Asked Questions
What is AKTS's premarket price?
Aktis Oncology (AKTS) is trading at $22.70 in premarket, down $8.45 (28.70%) from the previous close of $31.15.
Why is AKTS moving in premarket?
Aktis Oncology (AKTS) is down 28.70% from its previous close in premarket trading. Premarket moves are usually driven by company-specific news, earnings results, analyst rating or price-target changes, or broad market and sector sentiment. Check the latest AKTS premarket headlines and gap history below for the likely catalyst.
When does AKTS premarket trading start?
Premarket trading for AKTS on the NASDAQ runs from 4:00 AM to 9:30 AM Eastern Time, ahead of the regular session (9:30 AM – 4:00 PM ET). After-hours runs from 4:00 PM to 8:00 PM ET.
When does AKTS report earnings?
AKTS is expected to report earnings around Sep 2, 2026 (estimated), with an estimated EPS of $-0.42.